Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Promoting clinical trials in pediatric IgA nephropathy through extrapolation: an artificial intelligence-enhanced literature review of the disease in pediatrics sponsored by the Kidney Health Initiative.

Pediatric nephrology (Berlin, Germany)·2026
Same author

National Institutes of Health Workshop to Accelerate Therapeutic Innovation by Optimizing Kidney Precision Medicine Clinical Trials.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Strategies for the development of sodium-glucose cotransporter-2 inhibitors for kidney protection in pediatric chronic kidney disease: proceedings of a workshop meeting in July 2023.

Kidney international·2025
Same author

Reducing the Risks of Home Dialysis Innovation and Uptake: The Case for Human-Centered Product Design.

Clinical journal of the American Society of Nephrology : CJASN·2022
Same author

Sensitive diagnostic tools and targeted drug administration strategies are needed to eliminate schistosomiasis.

The Lancet. Infectious diseases·2020
Same author

Isotope-labeling derivatization with 3-nitrophenylhydrazine for LC/multiple-reaction monitoring-mass-spectrometry-based quantitation of carnitines in dried blood spots.

Analytica chimica acta·2018
Same journal

Erratum for the Research Article "Guanosine diphosphate-mannose suppresses homologous recombination repair and potentiates antitumor immunity in triple-negative breast cancer".

Science translational medicine·2026
Same journal

CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.

Science translational medicine·2026
Same journal

Bioresponsive microneedle stent provides anastomosis and postoperative adjuvant therapy in preclinical resectable intestinal diseases.

Science translational medicine·2026
Same journal

Alzheimer's disease proteome-wide association study implicates adaptive immunity and identifies risk genes LILRB1 and SIRPA.

Science translational medicine·2026
Same journal

KSHV-infected endothelial cells expand and up-regulate angiogenic pathways and CXCR4 in patient-derived Kaposi sarcoma models.

Science translational medicine·2026
Same journal

Hypoxia-driven T cell-macrophage-stromal cross-talk sustains fibrosis in preclinical models of cutaneous chronic graft-versus-host disease.

Science translational medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

Coral Reef Arks: An In Situ Mesocosm and Toolkit for Assembling Reef Communities
07:59

Coral Reef Arks: An In Situ Mesocosm and Toolkit for Assembling Reef Communities

Published on: January 6, 2023

4.1K

Consortium sandbox: building and sharing resources.

Mark D Lim1

  • 1FasterCures, A Center of the Milken Institute, Washington, DC 20005, USA.

Science Translational Medicine
|June 27, 2014
PubMed
Summary
This summary is machine-generated.

Directed consortia can help overcome biomedical product translation challenges by sharing resources. Analysis of 369 consortia shows this model benefits biomedical science but requires further optimization for full integration.

More Related Videos

The Collective Trust Game: An Online Group Adaptation of the Trust Game Based on the HoneyComb Paradigm
06:18

The Collective Trust Game: An Online Group Adaptation of the Trust Game Based on the HoneyComb Paradigm

Published on: October 20, 2022

2.5K
Kinematic History of a Salient-recess Junction Explored through a Combined Approach of Field Data and Analog Sandbox Modeling
06:55

Kinematic History of a Salient-recess Junction Explored through a Combined Approach of Field Data and Analog Sandbox Modeling

Published on: August 5, 2016

8.5K

Related Experiment Videos

Last Updated: Jan 14, 2026

Coral Reef Arks: An In Situ Mesocosm and Toolkit for Assembling Reef Communities
07:59

Coral Reef Arks: An In Situ Mesocosm and Toolkit for Assembling Reef Communities

Published on: January 6, 2023

4.1K
The Collective Trust Game: An Online Group Adaptation of the Trust Game Based on the HoneyComb Paradigm
06:18

The Collective Trust Game: An Online Group Adaptation of the Trust Game Based on the HoneyComb Paradigm

Published on: October 20, 2022

2.5K
Kinematic History of a Salient-recess Junction Explored through a Combined Approach of Field Data and Analog Sandbox Modeling
06:55

Kinematic History of a Salient-recess Junction Explored through a Combined Approach of Field Data and Analog Sandbox Modeling

Published on: August 5, 2016

8.5K

Area of Science:

  • Biomedical research
  • Translational science
  • Collaborative research models

Background:

  • Biomedical product translation faces challenges in scientific, regulatory, adoption, and reimbursement aspects.
  • Developing shared resources to address these challenges is hindered by the need for multi-sector expertise and cross-organizational validation.

Purpose of the Study:

  • To analyze the growth and impact of directed consortia in advancing biomedical research.
  • To understand how partnership frameworks can facilitate the development of shared resources for biomedical product translation.

Main Methods:

  • Analysis of 369 biomedical research consortia globally.
  • Tracking consortia growth and identifying patterns in their contribution to biomedical research.

Main Results:

  • Directed consortia provide a framework for neutral, temporary collaboration among diverse organizations.
  • Leveraging aggregated expertise and resources within consortia can create versatile solutions for biomedical challenges.
  • Consortia-based research demonstrates benefits to biomedical science.

Conclusions:

  • The directed consortia model offers a promising approach to address common challenges in biomedical product translation.
  • Further optimization of the consortia model is necessary for its seamless integration into the biomedical research pipeline.